PHARM3R Trademark
Trademark Overview
On Friday, May 5, 2023, a trademark application was filed for PHARM3R with the United States Patent and Trademark Office. The USPTO has given the PHARM3R trademark a serial number of 97922131. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by Pharm3r LLC. The PHARM3R trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Market intelligence services; Statistical evaluations of marketing data in the nature of collecting and analyzing consumer data and statistics; Market research and market intelligence services in the nature of aggregating market research results, data and statistics for analyzing, understanding, reporting and predicting drug and medical device efficacy and reliability to impact patient outcomes; Market research and market intelligence services for supply chain information management; preparation of marketing
reports, namely, creating reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes
providing medical information, namely, providing reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes
General Information
Serial Number | 97922131 |
Word Mark | PHARM3R |
Filing Date | Friday, May 5, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, November 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, October 15, 2024 |
Trademark Statements
Pseudo Mark | FARMER |
Goods and Services | Market intelligence services; Statistical evaluations of marketing data in the nature of collecting and analyzing consumer data and statistics; Market research and market intelligence services in the nature of aggregating market research results, data and statistics for analyzing, understanding, reporting and predicting drug and medical device efficacy and reliability to impact patient outcomes; Market research and market intelligence services for supply chain information management; preparation of marketing
reports, namely, creating reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes |
Goods and Services | providing medical information, namely, providing reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, June 4, 2023 |
Primary Code | 035 |
First Use Anywhere Date | Thursday, November 15, 2012 |
First Use In Commerce Date | Thursday, November 15, 2012 |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 27, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Pharm3r LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | New York, NY 10024 |
Party Name | Pharm3r LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | New York, NY 10024 |
Trademark Events
Event Date | Event Description |
Tuesday, May 9, 2023 | NEW APPLICATION ENTERED |
Sunday, June 4, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, January 31, 2024 | ASSIGNED TO EXAMINER |
Monday, February 5, 2024 | NON-FINAL ACTION WRITTEN |
Monday, February 5, 2024 | NON-FINAL ACTION E-MAILED |
Monday, February 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, March 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, August 27, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, August 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, August 27, 2024 | ASSIGNED TO LIE |
Tuesday, September 10, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 15, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, October 15, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |